Spotlight Growth
No Result
View All Result
Wednesday, February 8, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Bio/Med/Pharma

Canbiola, Inc. (OTCQB: CANB) Jumps 40% After Announcing Launch of the Sustained Acoustic Medicine (SAM) Wellness Solution

by admin
January 31, 2019
in Bio/Med/Pharma, Cannabis
0
Canbiola OTCQB CANB Launches Sustained Acoustic Medicine SAM Wellness Solution News

Canbiola OTCQB CANB Launches Sustained Acoustic Medicine SAM Wellness Solution News

Canbiola, Inc. (OTCQB: CANB) is engaged as a developer, manufacturer, and seller of a variety of hemp-based products. Shares jumped 40% on Thursday, January 31, 2019. Over the past month, Canbiola has seen an average daily volume of 3,138,461 shares. However, on Thursday, 9,132,974 shares traded hands, equating to $895,000 in dollar volume.

Shares surged on Thursday after Canbiola announced the launch of the Sustained Acoustic Medicine (SAM) wellness solution. This launch comes after the recent securing of the exclusive US distribution rights from the SAM developer, ZetrOZ Systems, LLC. SAM, “is proven in accelerating tissue healing and chronic pain reduction and is reimbursable by health insurance companies.” The SAM is the first and only “wearable low-intensity ultrasound device” to be approved by the FDA. Canbiola expects to purchase 1,650 units in 2019 for the purpose of renting out to medical offices, as well as direct-to-consumer sales. Each unit potentially represents $14,210 in gross revenue per year, according to Canbiola estimates. Marco Alfonsi, CEO of Canbiola, commented, “We are very excited in achieving this milestone of launching a revolutionary solution that addresses a much-needed void in the market to accelerate tissue healing and chronic pain reduction.” Here is the full press release detailing Canbiola’s launch of the SAM wellness solution:

Canbiola, Inc. Press Release:

HICKSVILLE, NY, Jan. 31, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, concentrate and water, announced today the launch and availability of a revolutionary Sustained Acoustic Medicine (“SAM”) wellness solution. SAM, along with its proprietary CBD Gel Capture Patches, is proven in accelerating tissue healing and chronic pain reduction and is reimbursable by health insurance companies.

The SAM Pro 2.0 is the first and only FDA cleared wearable low-intensity ultrasound device delivering multi-hour treatment to accelerate healing and improve function for musculoskeletal injuries (muscle, tendon, ligament) and reducing chronic pain (without opioid pain medication).

Canbiola and its Duramed subsidiary have attained exclusive distribution of SAM Pro 2.0 in the United States for no-fault insurance. Under its agreement with Sam International and ZetrOZ Systems, Canbiola is committed to purchasing 100 units per month starting in January and ramping to 150 units per month by June, for a total of 1,650 units for 2019.

Canbiola’s marketing strategy is to provide equipment and services to both medical offices as well as direct to consumer. We are presently billing and collecting from the insurance companies at $58 per day per unit. Given discussions with the medical community, including doctors and patients, the Company believes the patient will use the Sam unit and pads for an average of 35 days per cycle and that each unit will cycle an estimated 7 times per year. Thus, each unit potentially provides $14,210 in gross rental revenue per year.

Canbiola Chief Executive Officer Marco Alfonsi, commented, “We are very excited in achieving this milestone of launching a revolutionary solution that addresses a much-needed void in the market to accelerate tissue healing and chronic pain reduction. Our proprietary CBD gels coupled with the unique SAM delivery system, which we have exclusive U.S. rights within no-fault insurance to, will potentially drive our acceleration of both revenues and gross margins over the next twelve months.”

About Canbiola, Inc.

Canbiola, Inc. (OTCQB: CANB) is a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. For more information about Canbiola, Inc., please visit: https://canbiola.com

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect,” and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

Article By: Andrew Rego

Tags: acquisitionbiopharmaceuticalsbiotechCANBCanbiolacannabisCBD hempCBD oilCBDscommon stockconsumersemerging growthhealthhealthcarehemphemp oilinvestinginvestmentmarijuana stocksmedicalmedical cannabismedical marijuanamicrocap stocksnewsotc marketsotc stocksOTCQBpublic companysalesservicessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stocksstock marketstocksSustained Acoustic Medicinetradingtreatmentwellness
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Innovative Eyewear NASDAQ LUCY Lucyd Lyte 2 Smart Glasses Spotlight Growth

Innovative Eyewear (NASDAQ: LUCY) Debuts Lucyd Lyte 2.0 Audio Eyewear Product

February 7, 2023
American Resources Corporation NASDAQ AREC Reduced Debt By 9 Million Spotlight Growth

American Resources Corporation (NASDAQ: AREC) Reduces Debt by Over $9 Million

February 7, 2023
Its All Greek to Me What Are Option Greeks Spotlight Growth

It’s All Greek to Me: What Are Option Greeks and How Do They Impact Traders?

February 6, 2023
Unleashing the Power of 5G The Future of Mobile Technology Spotlight Growth

Unleashing the Power of 5G: The Future of Mobile Technology

February 6, 2023

Recent News

Innovative Eyewear NASDAQ LUCY Lucyd Lyte 2 Smart Glasses Spotlight Growth

Innovative Eyewear (NASDAQ: LUCY) Debuts Lucyd Lyte 2.0 Audio Eyewear Product

February 7, 2023
American Resources Corporation NASDAQ AREC Reduced Debt By 9 Million Spotlight Growth

American Resources Corporation (NASDAQ: AREC) Reduces Debt by Over $9 Million

February 7, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested